David Shaw’s KALA BIO KALA Stock Holding History

David Shaw’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-6	Closed	-$133K	–	4121
2020 Q1	$133K	Hold	6	–	–	﹤0.01%	3743
2019 Q4	$56K	Buy	+6	New	+$57.9K	﹤0.01%	3897

Other funds holding KALA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BOTOTLSJU

Board of Trustees of The Leland Stanford Junior University Redwood City, California $533M AUM 65.58% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

David Shaw's KALA Position: Q2 2022 in Review

David Shaw sold out of KALA BIO (KALA) in Q2 2022, closing a stake of 12 shares — an estimated $41K sold.

David Shaw first reported a position in KALA in Q1 2018 and held it in 11 quarters. The position peaked at $1.81M in Q2 2020. 63 funds tracked by Wall St. Rank hold KALA as of Q2 2022.

David Shaw reported no remaining KALA BIO position as of Q2 2022 after selling out during the quarter.
David Shaw sold 12 KALA BIO shares in Q2 2022, an estimated $41K.
David Shaw first reported a position in KALA BIO in Q1 2018 and held it in 11 quarters.
David Shaw's KALA BIO position peaked at $1.81M in Q2 2020.
63 funds tracked by Wall St. Rank held KALA BIO as of Q2 2022.

Based on D.E. Shaw & Co's 13F filing for Q2 2022, filed 15 Aug 2022.